Clinical Trial

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical Study Evaluating Nordlys™ System with Selective Waveband Technology (SWT)® Intense Pulsed Light (IPL) Applicators for Dry Eye Disease (DED) due to Meibomian Gland Dysfunction (MGD).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-09-26; most recent amendment 2025-08-18.
Status change: Recruiting → Active, Not Recruiting 2025-08-18
Trial Details
NCT Number NCT06064071
Lead Sponsor Candela Corporation
Conditions Meibomian Gland Dysfunction, Dry Eye Disease
Enrollment 100 participants
Start Date 2023-09-18
Primary Completion 2025-09 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-22